EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries

Genesee J Martinez iD, Malik Appleton, Zachary A Kipp iD, Analia S Loria iD, Booki Min, Terry D Hinds iD

Physiological Reviews · 01.01.2024 · 104 (1) · 473-532

DOI: 10.1152/physrev.00021.2023 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Physiological Reviews, erschienen am 01.01.2024. Verfasst von Genesee J Martinez und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, United States. Hauptthemen laut MEDLINE: Glucocorticoids, Hypothalamo-Hypophyseal System. Die Arbeit wurde bisher 112-mal zitiert (Crossref) und nennt 617 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMHD NIH HHS, NHLBI NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The normal stress response in humans is governed by the hypothalamic-pituitary-adrenal (HPA) axis through heightened mechanisms during stress, raising blood levels of the glucocorticoid hormone cortisol. Glucocorticoids are quintessential compounds that balance the proper functioning of numerous systems in the mammalian body. They are also generated synthetically and are the preeminent therapy for inflammatory diseases. They act by binding to the nuclear receptor transcription factor glucocorticoid receptor (GR), which has two main isoforms (GRα and GRβ). Our classical understanding of glucocorticoid signaling is from the GRα isoform, which binds the hormone, whereas GRβ has no known ligands. With glucocorticoids being involved in many physiological and cellular processes, even small disruptions in their release via the HPA axis, or changes in GR isoform expression, can have dire ramifications on health. Long-term chronic glucocorticoid therapy can lead to a glucocorticoid-resistant state, and we deliberate how this impacts disease treatment. Chronic glucocorticoid treatment can lead to noticeable side effects such as weight gain, adiposity, diabetes, and others that we discuss in detail. There are sexually dimorphic responses to glucocorticoids, and women tend to have a more hyperresponsive HPA axis than men. This review summarizes our understanding of glucocorticoids and critically analyzes the GR isoforms and their beneficial and deleterious mechanisms and the sexual differences that cause a dichotomy in responses. We also discuss the future of glucocorticoid therapy and propose a new concept of dual GR isoform agonist and postulate why activating both isoforms may prevent glucocorticoid resistance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlucocorticoidsHypothalamo-Hypophyseal SystemMaleAnimalsFemaleHumansSex CharacteristicsPituitary-Adrenal SystemReceptors, GlucocorticoidProtein IsoformsMammals

Stichwörter der Autor:innen

11β-HSD1HPA axisdual GR agonistglucocorticoid resistanceinflammation

Substanzen

GlucocorticoidsReceptors, GlucocorticoidProtein Isoforms

Autor:innen und Institutionen

  • Department of Pharmacology and Nutritional Sciences, University of Kentucky College of Medicine, Lexington, Kentucky, United States.
  • Barnstable Brown Diabetes Center, University of Kentucky College of Medicine, Lexington, Kentucky, United States.
  • Department of Microbiology and Immunology, Northwestern University Feinberg School of Medicine, Chicago, Illinois, United States.
  • Markey Cancer Center, University of Kentucky, Lexington, Kentucky, United States.

ORCID-Profile: Genesee J Martinez, Zachary A Kipp, Analia S Loria, Terry D Hinds

Förderung

  • NIMHD NIH HHS
  • NHLBI NIH HHS
  • NIAID NIH HHS
  • NCI NIH HHS
  • NIDA NIH HHS
  • NIDDK NIH HHS
  • Center for Strategic Scientific Initiatives, National Cancer Institute
  • HHS | NIH | National Institute on Minority Health and Health Disparities

Zitieren

APA

Martinez, G. J., Appleton, M., Kipp, Z. A., Loria, A. S., Min, B., & Hinds, T. D. (2024). Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries. Physiological Reviews, 104(1), 473-532. https://doi.org/10.1152/physrev.00021.2023

Vancouver

Martinez GJ, Appleton M, Kipp ZA, Loria AS, Min B, Hinds TD. Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries. Physiological Reviews. 2024;104(1):473-532. doi:10.1152/physrev.00021.2023

BibTeX
@article{Martinez2024,
  author = {Martinez, Genesee J and Appleton, Malik and Kipp, Zachary A and Loria, Analia S and Min, Booki and Hinds, Terry D},
  title = {Glucocorticoids, their uses, sexual dimorphisms, and diseases: new concepts, mechanisms, and discoveries},
  journal = {Physiological Reviews},
  year = {2024},
  volume = {104},
  number = {1},
  pages = {473--532},
  doi = {10.1152/physrev.00021.2023}
}
Kostenlos starten →